Hetland, G.; Fagerhol, M.K.; Mirlashari, M.R.; Nissen-Meyer, L.S.H.; Croci, S.; Lonati, P.A.; Bonacini, M.; Salvarani, C.; Marvisi, C.; Bodio, C.;
et al. Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy. Biomedicines 2024, 12, 766.
https://doi.org/10.3390/biomedicines12040766
AMA Style
Hetland G, Fagerhol MK, Mirlashari MR, Nissen-Meyer LSH, Croci S, Lonati PA, Bonacini M, Salvarani C, Marvisi C, Bodio C,
et al. Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy. Biomedicines. 2024; 12(4):766.
https://doi.org/10.3390/biomedicines12040766
Chicago/Turabian Style
Hetland, Geir, Magne Kristoffer Fagerhol, Mohammad Reza Mirlashari, Lise Sofie Haug Nissen-Meyer, Stefania Croci, Paola Adele Lonati, Martina Bonacini, Carlo Salvarani, Chiara Marvisi, Caterina Bodio,
and et al. 2024. "Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy" Biomedicines 12, no. 4: 766.
https://doi.org/10.3390/biomedicines12040766
APA Style
Hetland, G., Fagerhol, M. K., Mirlashari, M. R., Nissen-Meyer, L. S. H., Croci, S., Lonati, P. A., Bonacini, M., Salvarani, C., Marvisi, C., Bodio, C., Muratore, F., Borghi, M. O., & Meroni, P. L.
(2024). Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy. Biomedicines, 12(4), 766.
https://doi.org/10.3390/biomedicines12040766
